The Neuro-Innovation Era: Rapid-Acting Therapies and Personalized Medicine in the Depression Drug Market
Mental health has emerged as one of the most significant public health challenges of the 21st century, with major depressive disorder (MDD) affecting over 300 million people globally. For decades, the pharmaceutical industry relied on traditional antidepressants like SSRIs and SNRIs, which, while effective for many, often take weeks to show results and can have significant side effects. In...
0 Comentários 0 Compartilhamentos 86 Visualizações 0 Anterior